The current model which is daily pills and intermittent injections does not really work that well. The hope is that a medicine like VERVE101 can address that unmet need with a onetime therapy that produces deep and durable lowering of LDL Verve is testing the drug first in people with heterozygous familial hypercholesterolemia or HeFH an inherited condition that causes extremely high LDL levels and earlyonset atherosclerotic cardiovascular disease